Minimal N-methylated and stapled peptide ligands for the autophagy protein GABARAP

This study demonstrates that N-methylated and stapled peptide ligands can effectively stabilize the extended binding motif of LC3/GABARAP proteins, enabling the development of high-affinity, selective, and minimally charged tetrapeptide inhibitors with improved drug-like properties for targeting autophagy.

The Gist

The Big Picture: The Cell's Recycling Center

Imagine your body's cells are like giant, busy cities. To keep the city clean and running smoothly, it has a recycling center called autophagy. This center takes out the trash (broken proteins, damaged parts) and recycles it into new building materials.

The "foreman" of this recycling center is a protein called GABARAP. Its job is to grab onto the trash and load it onto a garbage truck (an autophagosome) to be taken to the dump (the lysosome).

The Problem: Sometimes, this recycling system goes into overdrive (which can cause cancer) or shuts down completely (which can lead to diseases like Alzheimer's). Scientists want to build a "key" that can either lock the foreman's hand shut (stop recycling) or unlock it (start recycling).

The Challenge: The "hand" of the GABARAP foreman is a long, shallow, flat groove. It's like trying to stick a key into a flat piece of wood rather than a keyhole. Most small keys (drugs) just slide right off because they can't get a good grip.

The Solution: Making Better "Keys"

The scientists in this paper tried to build better keys using pieces of the natural "trash tags" that cells use. These tags are called LIR motifs. Think of them as the specific stickers the trash has on it that tell the foreman, "Pick me up!"

The team tried two main tricks to make these stickers stickier and smaller:

1. The "Staple" Strategy (The Paperclip Method)

Imagine a long, floppy piece of string. It's hard to tie into a knot because it moves around too much.

• The Idea: If you take a paperclip and staple two parts of the string together, it forces the string to hold a specific shape.
• The Result: The scientists used chemical "staples" to lock their peptide strings into the exact shape needed to fit the GABARAP groove.
• The Twist: It worked, but only if the staple was placed in just the right spot. If they stapled it wrong, the string got too stiff and couldn't fit.

2. The "N-Methylation" Strategy (The Pre-Organized Suit)

This is the star of the show. Imagine you have a suit that is always wrinkled and messy when you take it out of the closet. You have to spend a lot of energy ironing it before you can wear it.

• The Idea: What if you could buy a suit that is already perfectly ironed and folded? You save energy, and you can put it on instantly.
• The Science: By adding a tiny methyl group (a tiny chemical "clip") to the backbone of the peptide, the scientists forced the molecule to stay in the "perfectly ironed" shape even before it touched the GABARAP protein.
• The Result: Because the molecule didn't have to waste energy changing its shape to fit, it grabbed onto the GABARAP much tighter and faster.

The Breakthrough: Shrinking the Key

Usually, to get a strong grip, you need a long, complex key with many teeth. But long keys are too big to fit through the cell's front door (the cell membrane).

The scientists wanted to shrink the key down to the absolute minimum size while keeping it sticky.

• The Original Key: A 9-piece chain (like a 9-link bracelet).
• The New Key: They chopped off the ends and used the "N-methylation" trick to hold the remaining pieces together.
• The Final Product: They created a tetrapeptide (a 4-link chain). It's tiny! It's so small and "dry" (lacking water-loving charges) that it can actually sneak through the cell's front door on its own, without needing a bodyguard to carry it in.

The Crystal Structure: The "Photo" Proof

To prove their theory, the scientists grew crystals of their new tiny key stuck to the GABARAP foreman and took an X-ray picture (a crystal structure).

• What they saw: The tiny 4-link key sat in the groove almost exactly like the big 9-link original.
• The Surprise: The "N-methyl" clip they added didn't touch the foreman at all. It just pointed out into the empty space. This proved that the clip's only job was to hold the key in the right shape before it arrived, acting like a pre-set spring.

Why This Matters

1. Drug Potential: Most drugs that try to stop autophagy are too big to get inside cells or don't stick well enough. These new tiny keys are small enough to enter cells and sticky enough to do the job.
2. Selectivity: The keys only lock onto the GABARAP foreman, not other similar proteins. This means fewer side effects.
3. Future Applications: These tiny keys could be used to:
   • Stop cancer cells from recycling their way out of treatment.
   • Help clear out toxic proteins in neurodegenerative diseases.
   • Act as a "tether" in Targeted Protein Degradation (a hot new field where you attach a drug to a "trash tag" to force the cell to eat a specific bad protein).

Summary Analogy

Think of the GABARAP protein as a Velcro strip on a wall.

• Old drugs were like fuzzy, floppy pieces of fabric that couldn't stick well.
• The Stapled peptides were like fabric that had been sewn into a rigid shape to fit the Velcro better.
• The N-Methylated peptides were like fabric that had been pre-ironed into the perfect shape.
• The Final Result: The scientists took a huge, heavy coat (the original protein), cut it down to a tiny, pre-ironed handkerchief (the tetrapeptide), and found that this tiny handkerchief stuck to the Velcro just as well as the coat, but it was small enough to fit in your pocket and walk right through the front door of a house.

Technical Summary

1. Problem Statement

The LC3/GABARAP protein family is a critical target for regulating macroautophagy and developing targeted protein degraders (PROTACs). However, these proteins present a significant challenge for small-molecule drug discovery due to their long, shallow binding grooves, which typically result in weak binding affinity for small molecules (micromolar range) and poor selectivity.

While peptide-based inhibitors exist, they often suffer from:

• Large size: Native LIR (LC3-interacting region) motifs are often long (e.g., 20-mers), and previous high-affinity stapled peptides were 12-mers, limiting cell permeability.
• Instability: Linear peptides are susceptible to proteolysis.
• Lack of cell penetration: Most current high-affinity ligands require micromolar concentrations to function in cells, likely due to poor passive permeability.

The authors aimed to develop minimal, drug-like peptidomimetics that retain sub-micromolar to nanomolar affinity for GABARAP while achieving passive cell permeability.

2. Methodology

The study utilized a structure-guided approach starting from a known high-affinity 9-mer peptide derived from the ULK1 protein (sequence: TDDFVMVPA), which contains the canonical LIR motif [W/F/Y]-X-X-[V/I/L].

Key Strategies Employed:

• Conformational Stabilization: Two distinct strategies were tested to pre-organize the peptide into the extended $\beta$-strand conformation required for binding:
  1. Side-chain Stapling: Introduction of $(i, i+2)$ and $(i, i+3)$ cross-links using para-dimethylbenzene (para-dmb) and meta-dmb linkers between cysteine residues.
  2. Backbone N-methylation: Systematic N-methylation of residues within the core LIR motif to restrict conformational freedom and reduce hydrogen bond donors.
• Sequence Optimization:
  • Substitution of Methionine with Norleucine (Nle) to prevent oxidation.
  • Replacement of the native Phenylalanine (Phe4) with Tryptophan (Trp) to enhance hydrophobic interactions.
  • Truncation: Systematic removal of N- and C-terminal residues to identify the minimal binding core.
• Biophysical Characterization:
  • Fluorescence Polarization (FP): To measure dissociation constants ($K_d$) for recombinant GABARAP.
  • AlphaScreen: To measure inhibitory potency ($IC_{50}$) in a competitive binding assay.
  • X-ray Crystallography: To determine the binding mode of the highest affinity N-methylated peptide.
  • Molecular Dynamics (MD) Simulations: To analyze the conformational ensembles of unbound peptides.
  • Permeability Assays: Parallel Artificial Membrane Permeability Assay (PAMPA) and MDCK cell monolayer assays to assess passive cell penetration.

3. Key Contributions and Results

A. Optimization of Stapled Peptides

• Initial stapling attempts at $(i, i+3)$ or $(i, i+2)$ positions using meta-dmb linkers resulted in loss of affinity.
• However, an $(i, i+2)$ staple using a para-dmb linker (Peptide M8) significantly improved affinity ($K_d = 218$ nM) compared to the unstapled control.
• Trp Substitution: Replacing Phe4 with Trp across all scaffolds yielded a ~10-fold affinity boost. The stapled Trp-analog (M14) achieved a $K_d$ of 15 nM.
• Selectivity: All optimized peptides retained >200-fold selectivity for GABARAP over LC3B.

B. Optimization of N-methylated Peptides

• N-methylation at key hydrogen-bonding residues (Val5, Val7) destroyed binding.
• Surprisingly, N-methylation at Nle6 (a solvent-exposed residue in the unbound state) increased affinity 5-fold ($K_d = 107$ nM for M11).
• Trp Substitution: Applying the Phe4 $\to$ Trp swap to the N-methylated scaffold (M15) resulted in the highest affinity ligand in the study: $K_d = 9.6$ nM.
• Crystal Structure: The crystal structure of M15 bound to GABARAP (1.42 Å resolution) revealed that the N-methylated peptide binds in an almost identical mode to the native ULK1 peptide (RMSD 0.1 Å). The N-methyl group at Nle6 points toward the solvent, suggesting the affinity gain is entropic (pre-organization of the unbound state) rather than enthalpic (new contacts).

C. Incompatibility of Strategies

• Combining stapling and N-methylation (Peptide M17) resulted in non-additive effects ($K_d = 71$ nM), performing worse than either modification alone.
• MD simulations suggested that stapling and N-methylation pre-organize the peptide backbone into different conformational ensembles. Combining them forces the central residue into a suboptimal conformation distinct from the preferred states of the individual modifications.

D. Minimalization and Permeability

• Truncation: The N-methylated peptide (M15) was successfully truncated to a tetrapeptide (M23, sequence: Trp-Nle(Me)-Val-Ala) by removing N- and C-terminal residues.
  • The tetrapeptide retained sub-micromolar affinity ($K_d = 162$ nM).
  • It contained no charged residues and only three backbone amides.
• Permeability:
  • Larger peptides (9-mers) showed negligible passive permeability in PAMPA assays.
  • The tetrapeptide (M23) and a further modified tripeptide analog (M24, lacking the N-terminal amide) demonstrated moderate passive permeability in PAMPA and enhanced permeability in MDCK assays.

4. Significance

• Drug-Like Space: This work successfully navigates the "drug-like" space for GABARAP ligands, moving from large, charged peptides to small, neutral, cell-permeable peptidomimetics.
• Mechanistic Insight: The study provides a rare example where N-methylation of a linear peptide enhances affinity for a $\beta$-strand binding partner by pre-organizing the unbound state, supported by crystallographic evidence showing the bound structure remains canonical.
• Therapeutic Application: The development of high-affinity, selective, and cell-permeable GABARAP ligands is a critical step forward for:
  1. Autophagy Modulation: Creating specific inhibitors to study autophagy in disease models.
  2. Targeted Protein Degradation (TPD): Serving as the "warhead" in autophagy-targeting chimeras (ATTECs) to degrade disease-causing proteins via the lysosome.
• Future Potential: The minimal tetrapeptide scaffold allows for solution-phase synthesis, enabling further chemical diversification (e.g., amide bond isosteres) to optimize pharmacokinetics and potency.

In conclusion, the authors have established a robust platform for generating minimal, high-affinity, and cell-permeable ligands for the challenging GABARAP target, overcoming the limitations of traditional small molecules and large peptides.